FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:267-268 July 28, 1994 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

All cancer staging systems seek to identify clinical and pathologic features that can predict outcome (prognosis) or in some cases guide therapy. The theme common to all staging systems for colorectal carcinoma is that the depth of invasion of the bowel wall and the presence or absence of lymph-node involvement are powerful predictors of whether or not the cancer will recur. Other prognostic features, such as sex, tumor site within the colon, tumor grade, and the degree of local invasion, perforation, or obstruction,¹ which may not appear in pathologic staging systems, are often used as stratification factors in the design . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., Tu, D., Redston, M., Gallinger, S. (2003). Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer. NEJM 349: 247-257 [Abstract] [Full Text]  
• (1994). GENETIC MARKERS AND PROGNOSIS OF COLORECTAL CANCER. JWatch General 1994: 4-4 [Full Text]